(Q38356895)

English

Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological increti

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological increti (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

0 references

author name string

V A Gault

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

F P M O'Harte

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

P Harriott

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

M H Mooney

4

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

B D Green

5

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

P R Flatt

6

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

publication date

12 February 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

222-230

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

https://scigraph.springernature.com/pub.10.1007/s00125-002-1028-x

0 references

Pancreatic B-cells as mediators of metabolic effects of regulatory peptides

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-1028-X

21 January 2018

The metabolic role of GIP: physiology and pathology

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-1028-X

21 January 2018

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-1028-X

21 January 2018

Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for type 2-diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-1028-X

21 January 2018

Amino terminal glycation of gastric inhibitory polypeptide enhances its insulinotropic action on clonal pancreatic B-cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-1028-X

21 January 2018

Improved glycaemic control in obese diabetic ob/ob mice using N-terminally modified gastric inhibitory polypeptide

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-1028-X

21 January 2018

Reduced insulinotropic effects of glucagonlike peptide I-(7-36)-amide and gastric inhibitory polypeptide in isolated perfused diabetic rat pancreas.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-1028-X

21 January 2018

Glucagon-like peptide-1 is a physiological incretin in rat

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-1028-X

21 January 2018

Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-1028-X

21 January 2018

Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-1028-X

21 January 2018

Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-1028-X

21 January 2018

Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-1028-X

21 January 2018

Functional expression of the rat pancreatic islet glucose-dependent insulinotropic polypeptide receptor: ligand binding and intracellular signaling properties.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-1028-X

21 January 2018

Enhanced glucose-dependent insulinotropic polypeptide secretion and insulinotropic action in glucagon-like peptide 1 receptor -/- mice

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-1028-X

21 January 2018

Glucose intolerance caused by a defect in the entero-insular axis: a study in gastric inhibitory polypeptide receptor knockout mice

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-1028-X

21 January 2018

Characterization of the cellular and metabolic effects of a novel enzyme-resistant antagonist of glucose-dependent insulinotropic polypeptide

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-1028-X

21 January 2018

Characterization of a novel glucose-responsive insulin-secreting cell line, BRIN-BD11, produced by electrofusion.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-1028-X

21 January 2018

Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-1028-X

21 January 2018

Dipeptidyl peptidase IV inhibition reduces the degradation and clearance of GIP and potentiates its insulinotropic and antihyperglycemic effects in anesthetized pigs

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-1028-X

21 January 2018

Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-1028-X

21 January 2018

Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-1028-X

21 January 2018

Both Subcutaneously and Intravenously Administered Glucagon-Like Peptide I Are Rapidly Degraded From the NH2-Terminus in Type II Diabetic Patients and in Healthy Subjects

1 reference

https://api.crossref.org/works/10.1007%2FS00125-002-1028-X

21 January 2018

Pancreatic alpha- and beta-cell responses to GIP infusion in normal man

1 reference

https://pubmed.ncbi.nlm.nih.gov/12627321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV

1 reference

https://pubmed.ncbi.nlm.nih.gov/12627321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucagonlike peptide 1: a newly discovered gastrointestinal hormone

1 reference

https://pubmed.ncbi.nlm.nih.gov/12627321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the effect of GIP and GLP-1 (7-36amide) on insulin release from rat pancreatic islets

1 reference

https://pubmed.ncbi.nlm.nih.gov/12627321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determination of glucose by an automatic analyser

1 reference

https://pubmed.ncbi.nlm.nih.gov/12627321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of glucagon-like peptide-1 on insulin secretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/12627321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/12627321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulation of insulin secretion by gastric inhibitory polypeptide in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/12627321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids

1 reference

https://pubmed.ncbi.nlm.nih.gov/12627321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations

1 reference

https://pubmed.ncbi.nlm.nih.gov/12627321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Signal transduction by the cloned glucagon-like peptide-1 receptor: comparison with signaling by the endogenous receptors of beta cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/12627321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12627321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide

1 reference

https://pubmed.ncbi.nlm.nih.gov/12627321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of GLP-1 (7-36amide) and GIP on release of somatostatin-like immunoreactivity and insulin from the isolated rat pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/12627321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39

1 reference

https://pubmed.ncbi.nlm.nih.gov/12627321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Investigation of glucose-dependent insulinotropic polypeptide-(1-42) and glucagon-like peptide-1-(7-36) degradation in vitro by dipeptidyl peptidase IV using matrix-assisted laser desorption/ionization-time of flight mass spectrometry. A novel [...]

1 reference

https://pubmed.ncbi.nlm.nih.gov/12627321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of genetic background and age on the expression of the obese hyperglycaemic syndrome in Aston ob/ob mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/12627321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/12627321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of GIP and GLP-1 antagonists on insulin release in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/12627321

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-002-1028-X

0 references

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38356895&oldid=1509442715"